SCHEDULE 13G/A: Vanguard Group Discloses 10.69% Stake in RXO Inc Common Stock
Beneficial Ownership Statement
The Vanguard Group has filed an amended Schedule 13G, reporting a beneficial ownership of 10.69% of RXO Inc's Common Stock as of December 31, 2024.
Summary
- The Vanguard Group reported beneficial ownership of 17,203,721 shares of RXO Inc Common Stock.
- This represents 10.69% of the total class of securities.
- Vanguard holds sole dispositive power over 16,775,442 shares and shared dispositive power over 428,279 shares.
- Vanguard holds no sole voting power, but has shared voting power over 287,024 shares.
- This filing is Amendment No. 5, indicating a series of previous ownership disclosures by Vanguard regarding RXO Inc.
- The Vanguard Group certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of RXO Inc.
Sentiment
Score: 6
Explanation: The disclosure of a significant stake by a major institutional investor like Vanguard is generally viewed as a neutral to slightly positive signal, indicating institutional confidence without implying active control or specific operational issues.
Positives
- A significant stake by a major institutional investor like The Vanguard Group can signal confidence in the company's long-term prospects and stability.
- The passive nature of the investment, as indicated by the Schedule 13G filing, suggests that Vanguard is not seeking to influence control, which can be viewed positively by management and other shareholders as it implies no immediate activist pressure.
Risks
- As a passive investor, The Vanguard Group does not intend to influence the control or management of RXO Inc, meaning their significant stake does not imply active strategic guidance or intervention in the company's operations.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of beneficial ownership by a large institutional investor and does not provide specific insights into broader industry trends or the competitive landscape for RXO Inc.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holder, potentially influencing investor sentiment and liquidity.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (beneficial ownership calculation date). |
| 01/08/2025 | Date the Schedule 13G Amendment No. 5 was signed and filed. |
Keywords
RXO Inc, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Ownership Disclosure, Passive Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.